908 Devices, a pioneer of purpose-built analytical devices for chemical analysis, today announced it has raised additional growth equity investment for acceleration into the life sciences market, completing its Series C funding and bringing the Company’s funding total to $29 Million. Industry leaders Casdin Capital, a leading life science investor; Dr. Martin Madaus, Chairman and […]

FARMINGDALE, N.Y.– Cemtrex Inc. (CTEI), a diversified industrial and manufacturing technology company, announced today that its common shares will commence trading on the NASDAQ Capital Markets. The company’s common stock will begin trading under a new symbol “CETX” on Thursday, June 25th, 2015. Cemtrex has demonstrated tremendous growth in recent years reaching over $47 million […]

HOLLISTON, Mass. — Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, is set to simultaneously join two broad-market Russell indexes. According to Russell’s preliminary list of additions, the Company is expected to be added to the Russell 3000® Index and the Russell Global […]

Hayward, CA –– Advanced Cell Diagnostics, Inc. (ACD), a world leader in the field of in situ nucleic acid detection for life science research and clinical diagnostics, announced today that it has raised $22 million in Series C equity financing, led by growth equity investor Summit Partners with participation from Kenson Ventures and existing investors, […]

Stratos Genomics Inc. announced today it achieved a major technical milestone last month by demonstrating nanopore sequencing with their proprietary expandable nucleotides (X-NTP™). Stratos’ Sequencing by Expansion technology (SBX™) is an efficient, low-cost DNA preparation method that rescales a DNA target into a longer surrogate polymer. This surrogate, called an Xpandomer™, encodes the sequence information […]

PROVO, Utah – Tute Genomics, a leader in cloud-based analytics, interpretation, and reporting for clinical sequencing, today announced the closing of its Series A1 round of venture capital funding. The company raised over $3.9 million from a strategic group of investors, including internationally recognized Intermountain Healthcare, an integrated network of 22 hospitals and 185 physician […]

Madison, WI – The National Institute for Neurological Disorders and Stroke has awarded a Phase I Small Technology Transfer Research grant to BellBrook Labs and collaborators at the University of Wisconsin-Madison to develop a microfluidic platform for high throughput imaging of neuronal transport. Transport of cellular cargo between cell bodies and nerve endings is critical […]

Fluidic Analytics is a spin-out from the University of Cambridge that is developing products based on a disruptive technology for protein characterisation. Proteins are the direct, real-time indicators of the state of a biological system. While DNA gives information about how people and organisms will develop over their entire lifetimes, proteins give information about how […]